Sunday 11 October 2026 Export all NVO data to Excel Powerpack

Novo Nordisk A/S

NVO Healthcare Drug Manufacturers General

Novo Nordisk A/S’s revenue for fiscal 2025 (year ended December 2025) was $46.8 billion, up 11.1% from fiscal 2024. In the quarter to June 2026, revenue grew 4.47%, EPS fell 18.7%, free cash flow grew 71.6% and total debt rose 44.4%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for five.

38.64 0.46 +1.20%
Market cap
$127.8B
P/E
9.4×
Fwd P/E
—
Dividend yield
4.65%
F-score
5/9
Altman Z
4.32
Beneish M
−2.51
Dividend safety
46/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
16.11 23.24 18.21 23.53 25.40 33.84 39.47 37.75 26.15 14.66
Piotroski F-Score
7 6 6 4 5 4 6 8 5 5
P/S ratio
5.47 7.89 6.52 7.51 8.38 11.48 12.38 13.57 9.10 4.83
Altman Z-Score
10.61 13.47 10.57 11.11 10.51 9.99 10.40 11.38 6.74 4.32
Altman Z″-Score (non-manufacturers)
6.62 6.61 5.65 5.38 4.56 3.36 3.38 3.19 2.53 2.81
P/FCF ratio
15.27 27.11 22.63 25.78 35.62 33.96 34.16 45.03 37.93 51.51
Beneish M-Score
(3.03) (2.63) (2.51) (2.67) (2.29) (2.12) (2.86) (2.55) (2.49) (2.51)
P/Operating CF
56.61 190.83 109.53 169.31 (956.79) (570.41) 212.83 350.14 251.59 393.97
Dividend Safety Score
— — — — — — — — — 46
P/B ratio
13.51 17.70 14.07 15.92 16.81 22.86 26.24 29.58 18.41 7.69
EV/Sales
5.28 7.72 6.38 7.42 8.36 11.54 12.38 13.55 9.34 5.15
EV/EBITDA
11.44 16.54 13.95 15.58 17.73 25.12 26.66 28.10 18.40 10.63
EV/FCF
14.74 26.51 22.16 25.47 35.54 34.12 34.16 44.95 38.94 54.86
Current Ratio
1.26 1.28 1.09 1.06 0.94 0.86 0.89 0.82 0.74 0.80
Net Debt/EBITDA
(0.41) (0.37) (0.30) (0.19) (0.04) 0.12 (0.01) (0.05) 0.48 0.65
Debt/Equity
0.01 0.03 0.01 0.08 0.16 0.38 0.31 0.25 0.72 0.67
ROE
82.18% 81.04% 76.24% 70.52% 70.42% 72.51% 68.14% 89.04% 80.73% 61.81%
ROA
40.03% 38.56% 36.36% 32.65% 31.47% 28.59% 24.15% 30.44% 25.87% 20.71%
ROIC
124.72% 100.83% 80.88% 70.67% 55.53% 46.86% 56.35% 63.48% 37.55% 27.38%
Return on Tangible Assets
89.22% 78.99% 82.55% 72.10% 91.99% 115.24% 102.97% 137.29% 95.40% 62.02%
Average Days of Receivables
79.01 76.96 87.76 87.20 92.54 121.32 118.61 118.27 109.87 105.33
Earnings Yield
6.21% 4.30% 5.49% 4.25% 3.94% 2.96% 2.53% 2.65% 3.82% 6.82%
Free Cash Flow Yield
6.55% 3.69% 4.42% 3.88% 2.81% 2.94% 2.93% 2.22% 2.64% 1.94%
Free Cash Flow per Share
1.18 1.00 1.02 1.12 0.98 1.65 2.00 2.27 2.27 0.99
Book value per Share
1.33 1.53 1.64 1.82 2.08 2.45 2.61 3.45 4.67 6.61
Free Cash Flow
5,952.02 4,941.16 4,926.29 5,329.69 4,577.16 7,575.55 9,081.37 10,165.74 10,100.56 4,388.93
EV/EBIT
12.19 17.61 15.11 17.26 19.62 27.70 29.28 30.68 21.13 12.46
Other line items

Show all line items

Columns are period end dates